Back to search
Fetal Alcohol Syndrome (FAS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fetal Alcohol Syndrome (FAS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Fetal Alcohol Syndrome (FAS) trials you may qualify forThe flavonoid epigallocatechin gallate (EGCG) is a modulator of neuronal plasticity useful in other neurodevelopmental diseases. A recent study showed that EGCG…
The purpose of this study is to help scientists understand why some people who were exposed to alcohol in the womb have special facial features but other people…
Determine if atomoxetine is safe and well tolerated by children with fetal alcohol syndrome.
The purpose of this study is to determine if atomoxetine hydrochloride improves inattention, hyperactivity, and impulsivity problems in children exposed to alco…
The purpose of this study is to determine if choline bitartrate can be administered daily to children with prenatal alcohol exposure, ages 2.5 to 5, as a potent…
The purpose of this study is to evaluate an intervention aimed at reducing risk for alcohol-exposed pregnancies and preventing Fetal Alcohol Spectrum Disorders…
This trial will pilot test intervention strategies to increase utilization of HIV testing and gain knowledge for designing a clinical trial to evaluate preventi…
This study is designed to increase knowledge and awareness to prevent Fetal Alcohol Syndrome in Russian children through development of printed FAS education ma…
Evaluating the efficacy of a video about FAS to determine whether it has an impact on knowledge about FAS and their likelihood to participate in risk taking beh…
Children will receive comprehensive evaluations through the Children's Research Triangle (CRT) clinical program. The assessment for the child will be in accorda…